secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vanda Pharmaceuticals Inc. (VNDA)
CIK:        0001347178
Form:       8-K
Filed at:   2024-06-13T23:59:59+00:00
Accession:  0001193125-24-160755
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.75
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Vanda confirms revised unsolicited takeover proposal from Future Pak at $8.50-$9.00 per share plus CVRs
--------------------------------------------------------------------------------

- Future Pak LLC proposes $8.50-$9.00 per share cash plus Contingent Value Rights for Vanda Pharmaceuticals.
- Vanda Board will review the revised non-binding proposal with financial and legal advisors.
- No shareholder action required at this time; company will not comment further until Board completes review.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1347178/000119312524160755/0001193125-24-160755-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1347178/000119312524160755/d843445d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-160755

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer